About
Technology
Issues
FAQ
Links
Official Page
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.